ABEONA THERAPEUTICS INC. Loss Contingency, Number of Defendants
ABEONA THERAPEUTICS INC. (ABEO) reported Loss Contingency, Number of Defendants of 30 Defendant for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyNumberOfDefendants · last filed 2015-11-16
- ABEONA THERAPEUTICS INC. loss contingency, number of defendants for the quarter ending 2015-03-31 was 30.00 Defendant.
| Period end | Loss Contingency, Number of Defendants 3 month | Loss Contingency, Number of Defendants 6 month | Loss Contingency, Number of Defendants 9 month |
|---|---|---|---|
| 2015-09-30 | 30.00 Defendant 10-Q · filed 2015-11-16 | ||
| 2015-06-30 | 30.00 Defendant 10-Q · filed 2015-08-14 | ||
| 2015-03-31 | 30.00 Defendant 10-Q · filed 2015-05-14 | ||
| 2014-09-30 | 30.00 Defendant 10-Q · filed 2014-11-14 | ||
| 2014-06-30 | 30.00 Defendant 10-Q · filed 2014-08-14 | ||
| 2013-06-30 | 30.00 Defendant 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |